{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:51:11Z","timestamp":1788511871118,"version":"build-2803163510"},"reference-count":118,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ccm.2025.02.002","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T22:25:44Z","timestamp":1749248744000},"page":"227-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of Malignant Pleural Effusions"],"prefix":"10.1016","volume":"46","author":[{"given":"Rebecca","family":"Crook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Maskell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ccm.2025.02.002_bib1","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1164\/ajrccm.162.5.ats8-00","article-title":"Management of malignant pleural effusions","volume":"162","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccm.2025.02.002_bib2","article-title":"Interventions for the management of malignant pleural effusions: a network meta-analysis","volume":"2016","author":"Clive","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 2","key":"10.1016\/j.ccm.2025.02.002_bib3","doi-asserted-by":"crossref","first-page":"ii32","DOI":"10.1136\/thx.2010.136994","article-title":"Management of a malignant pleural effusion: British thoracic society pleural disease guideline 2010","volume":"65","author":"Roberts","year":"2010","journal-title":"Thorax"},{"issue":"Suppl 3","key":"10.1016\/j.ccm.2025.02.002_bib4","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/thorax-2022-219784","article-title":"British thoracic society guideline for pleural disease","volume":"78","author":"Roberts","year":"2023","journal-title":"Thorax"},{"issue":"140","key":"10.1016\/j.ccm.2025.02.002_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1183\/16000617.0019-2016","article-title":"Malignant pleural effusion: from bench to bedside","volume":"25","author":"Psallidas","year":"2016","journal-title":"Eur Respir Rev"},{"issue":"5","key":"10.1016\/j.ccm.2025.02.002_bib6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejim.2007.09.014","article-title":"Prognostic significance of pleural fluid data in patients with malignant effusion","volume":"19","author":"Bielsa","year":"2008","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1378\/chest.117.1.73","article-title":"Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease","volume":"117","author":"Burrows","year":"2000","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.ccm.2025.02.002_bib8","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/thoraxjnl-2014-205285","article-title":"Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score","volume":"69","author":"Clive","year":"2014","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.ccm.2025.02.002_bib9","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S1470-2045(18)30294-8","article-title":"Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis","volume":"19","author":"Psallidas","year":"2018","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib10","doi-asserted-by":"crossref","first-page":"1800349","DOI":"10.1183\/13993003.00349-2018","article-title":"ERS\/EACTS statement on the management of malignant pleural effusions","volume":"52","author":"Bibby","year":"2018","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ccm.2025.02.002_bib11","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1378\/chest.104.5.1482","article-title":"Survival and talc pleurodesis in metastatic pleural carcinoma, revisited. Report of 125 cases","volume":"104","author":"Sanchez-Armengol","year":"1993","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccm.2025.02.002_bib12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000029240","article-title":"Malignant pleural effusion: prognostic factors for survival and response to chemical pleurodesis in a series of 120 cases","volume":"65","author":"Mart\u00ednez-Morag\u00f3n","year":"1998","journal-title":"Respiration"},{"issue":"3","key":"10.1016\/j.ccm.2025.02.002_bib13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/0003-4819-108-3-345","article-title":"Pleural fluid pH in malignant effusions. Diagnostic, prognostic, and therapeutic implications","volume":"108","author":"Sahn","year":"1988","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ccm.2025.02.002_bib14","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1378\/chest.95.2.320","article-title":"Survival time of patients with pleural metastatic carcinoma predicted by glucose and pH studies","volume":"95","author":"Rodriguez-Panadero","year":"1989","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejim.2009.09.012","article-title":"Predictors of mortality within three months in the patients with malignant pleural effusion","volume":"21","author":"Ozyurtkan","year":"2010","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000226786","article-title":"Malignant pleural effusions: meaning of pleural-fluid pH determination","volume":"47","author":"Foresti","year":"1990","journal-title":"Oncology"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1378\/chest.117.1.79","article-title":"Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions","volume":"117","author":"Heffner","year":"2000","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.ccm.2025.02.002_bib18","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.rmed.2005.02.022","article-title":"Etiology and prognostic significance of massive pleural effusions","volume":"99","author":"Jim\u00e9nez","year":"2005","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.ccm.2025.02.002_bib19","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S2213-2600(19)30373-X","article-title":"Malignant pleural effusion management: keeping the flood gates shut","volume":"8","author":"Walker","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"12","key":"10.1016\/j.ccm.2025.02.002_bib20","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/resp.13837","article-title":"Malignant pleural effusion survival prognostication in an Asian population","volume":"25","author":"Quek","year":"2020","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.ccm.2025.02.002_bib21","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000489315","article-title":"An observational study evaluating the performance of LENT score in the selected population of malignant pleural effusion from lung adenocarcinoma in Singapore","volume":"96","author":"Abisheganaden","year":"2018","journal-title":"Respiration"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib22","article-title":"Assessment of patient-reported outcome measures in pleural interventions","volume":"4","author":"Psallidas","year":"2017","journal-title":"BMJ Open Respir Res"},{"issue":"2","key":"10.1016\/j.ccm.2025.02.002_bib23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.chest.2017.08.026","article-title":"Quality gaps and comparative effectiveness of management strategies for recurrent malignant pleural effusions","volume":"153","author":"Ost","year":"2018","journal-title":"Chest"},{"issue":"Suppl 1","key":"10.1016\/j.ccm.2025.02.002_bib24","first-page":"A152","article-title":"P131 Pleural nurse specialists: an evolving role within the national health service","volume":"77","author":"Li","year":"2022","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib25","article-title":"Critical analysis of the utility of initial pleural aspiration in the diagnosis and management of suspected malignant pleural effusion","volume":"7","author":"Mercer","year":"2020","journal-title":"BMJ Open Respir Res"},{"issue":"3","key":"10.1016\/j.ccm.2025.02.002_bib26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0003-4975(10)62480-0","article-title":"Reexpansion pulmonary edema","volume":"45","author":"Mahfood","year":"1988","journal-title":"Ann Thorac Surg"},{"issue":"8","key":"10.1016\/j.ccm.2025.02.002_bib27","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1080\/02841850410008270","article-title":"Pneumothorax and the value of chest radiography after ultrasound-guided thoracocentesis","volume":"45","author":"Pihlajamaa","year":"2004","journal-title":"Acta Radiol"},{"issue":"2","key":"10.1016\/j.ccm.2025.02.002_bib28","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1378\/chest.123.2.418","article-title":"Ultrasound-guided thoracentesis: is it a safer method?","volume":"123","author":"Jones","year":"2003","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccm.2025.02.002_bib29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/thoraxjnl-2014-206114","article-title":"Thoracentesis outcomes: a 12-year experience","volume":"70","author":"Ault","year":"2015","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.ccm.2025.02.002_bib30","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.chest.2024.05.046","article-title":"Gravity- vs wall suction-driven large-volume thoracentesis: a randomized controlled study","volume":"166","author":"Shojaee","year":"2024","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.ccm.2025.02.002_bib31","first-page":"1058","article-title":"Pleural procedural complications: prevention and management","volume":"7","author":"Corcoran","year":"2015","journal-title":"J Thorac Dis"},{"issue":"Suppl 3","key":"10.1016\/j.ccm.2025.02.002_bib32","doi-asserted-by":"crossref","first-page":"s43","DOI":"10.1136\/thorax-2022-219371","article-title":"British thoracic society clinical statement on pleural procedures - appendices 1-4","volume":"78","author":"Asciak","year":"2023","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.ccm.2025.02.002_bib33","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MCP.0000000000000285","article-title":"Complications of thoracentesis: incidence, risk factors, and strategies for prevention","volume":"22","author":"Cantey","year":"2016","journal-title":"Curr Opin Pulm Med"},{"issue":"11","key":"10.1016\/j.ccm.2025.02.002_bib35","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1007\/s00520-013-1895-3","article-title":"Comparison of modified Borg scale and visual analog scale dyspnea scores in predicting re-intervention after drainage of malignant pleural effusion","volume":"21","author":"Boshuizen","year":"2013","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/resp.13362","article-title":"Risk factors for pleural effusion recurrence in patients with malignancy","volume":"24","author":"Grosu","year":"2019","journal-title":"Respirology"},{"key":"10.1016\/j.ccm.2025.02.002_bib37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3310\/nihropenres.13282.1","volume":"3","author":"Mishra","year":"2023","journal-title":"NIHR Open Res"},{"issue":"7","key":"10.1016\/j.ccm.2025.02.002_bib38","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1164\/rccm.201807-1415ST","article-title":"Management of malignant pleural effusions. An official ATS\/STS\/STR clinical practice guideline","volume":"198","author":"Feller-Kopman","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.7326\/0003-4819-120-1-199401010-00010","article-title":"Chemical pleurodesis for malignant pleural effusions","volume":"120","author":"Walker-Renard","year":"1994","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.ccm.2025.02.002_bib40","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ejcts.2005.12.025","article-title":"The evidence on the effectiveness of management for malignant pleural effusion: a systematic review","volume":"29","author":"Tan","year":"2006","journal-title":"Eur J Cardio Thorac Surg"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087060","article-title":"Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis","volume":"9","author":"Xia","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ccm.2025.02.002_bib42","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1164\/rccm.200311-1579OC","article-title":"Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size","volume":"170","author":"Maskell","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccm.2025.02.002_bib43","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000342042","article-title":"Small particle-size talc is associated with poor outcome and increased inflammation in thoracoscopic pleurodesis","volume":"86","author":"Arellano-Orden","year":"2013","journal-title":"Respiration"},{"issue":"3","key":"10.1016\/j.ccm.2025.02.002_bib44","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1378\/chest.93.3.527","article-title":"Effect of patient positioning on distribution of tetracycline in the pleural space during pleurodesis","volume":"93","author":"Lorch","year":"1988","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0169-5002(01)00475-5","article-title":"Distribution of talc suspension during treatment of malignant pleural effusion with talc pleurodesis","volume":"36","author":"Mager","year":"2002","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.ccm.2025.02.002_bib46","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1378\/chest.104.6.1763","article-title":"A comparison of rotation and nonrotation in tetracycline pleurodesis","volume":"104","author":"Dryzer","year":"1993","journal-title":"Chest"},{"issue":"24","key":"10.1016\/j.ccm.2025.02.002_bib47","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1001\/jama.2015.16840","article-title":"Effect of opioids vs NSAIDs and larger vs smaller chest tube size on pain control and pleurodesis efficacy among patients with malignant pleural effusion: the TIME1 randomized clinical trial","volume":"314","author":"Rahman","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib48","doi-asserted-by":"crossref","first-page":"355","DOI":"10.21037\/jtd.2017.11.134","article-title":"Effect of chest tube size on pleurodesis efficacy in malignant pleural effusion: a meta-analysis of randomized controlled trials","volume":"10","author":"Thethi","year":"2017","journal-title":"J Thorac Dis"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/thx.49.1.23","article-title":"Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions","volume":"49","author":"Villanueva","year":"1994","journal-title":"Thorax"},{"issue":"12","key":"10.1016\/j.ccm.2025.02.002_bib50","first-page":"1731","article-title":"Rapid pleurodesis is an outpatient alternative in patients with malignant pleural effusions: a prospective randomized controlled trial","volume":"6","author":"\u00d6zkul","year":"2014","journal-title":"J Thorac Dis"},{"issue":"suppl 67","key":"10.1016\/j.ccm.2025.02.002_bib51","article-title":"To study the efficacy of time dependant vs volume dependant chest drain removal protocol for talc slurry pleurodesis in patients with malignant pleural effusion","volume":"62","author":"Gupta","year":"2023","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib52","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.lungcan.2006.06.004","article-title":"Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial","volume":"54","author":"Goodman","year":"2006","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejcts.2004.08.034","article-title":"Rapid pleurodesis in symptomatic malignant pleural effusion","volume":"27","author":"Yildirim","year":"2005","journal-title":"Eur J Cardio Thorac Surg"},{"issue":"5","key":"10.1016\/j.ccm.2025.02.002_bib54","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.amjsurg.2021.04.008","article-title":"Beyond the tube: can we reduce chest tube complications in trauma patients?","volume":"222","author":"Platnick","year":"2021","journal-title":"Am J Surg"},{"issue":"3","key":"10.1016\/j.ccm.2025.02.002_bib55","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1378\/chest.127.3.909","article-title":"Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion","volume":"127","author":"Dresler","year":"2005","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.ccm.2025.02.002_bib56","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.ejcts.2006.10.002","article-title":"Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study","volume":"30","author":"Stefani","year":"2006","journal-title":"Eur J Cardio Thorac Surg"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib57","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13019-021-01475-1","article-title":"Complications of thoracoscopic talc insufflation for the treatment of malignant pleural effusions: a meta-analysis","volume":"16","author":"Zhang","year":"2021","journal-title":"J Cardiothorac Surg"},{"issue":"6","key":"10.1016\/j.ccm.2025.02.002_bib58","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1164\/ajrccm.162.6.pc09-00a","article-title":"Talc should Be used for pleurodesis","volume":"162","author":"Sahn","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"9572","key":"10.1016\/j.ccm.2025.02.002_bib59","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(07)60708-9","article-title":"Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study","volume":"369","author":"Janssen","year":"2007","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.ccm.2025.02.002_bib60","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1001\/jama.2012.5535","article-title":"Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial","volume":"307","author":"Davies","year":"2012","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ccm.2025.02.002_bib61","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1164\/rccm.201704-0809OC","article-title":"Randomized controlled trial of urokinase versus placebo for nondraining malignant pleural effusion","volume":"197","author":"Mishra","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.ccm.2025.02.002_bib62","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00268-004-7269-8","article-title":"Pleurodesis in patients with malignant pleural effusions: talc slurry or bleomycin? Results of a prospective randomized trial","volume":"28","author":"Haddad","year":"2004","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.ccm.2025.02.002_bib63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1440-1843.2000.00235.x","article-title":"A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions","volume":"5","author":"Ong","year":"2000","journal-title":"Respirology"},{"issue":"6","key":"10.1016\/j.ccm.2025.02.002_bib64","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0003-4975(96)00808-9","article-title":"Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion","volume":"62","author":"Yim","year":"1996","journal-title":"Ann Thorac Surg"},{"issue":"7","key":"10.1016\/j.ccm.2025.02.002_bib65","doi-asserted-by":"crossref","first-page":"351","DOI":"10.12968\/ijpn.2016.22.7.351","article-title":"A prospective study of patient-centred outcomes in the management of malignant pleural effusions","volume":"22","author":"Walker","year":"2016","journal-title":"Int J Palliat Nurs"},{"issue":"6","key":"10.1016\/j.ccm.2025.02.002_bib66","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/bja\/aer143","article-title":"Efficacy and safety of thoracic paravertebral block for medical thoracoscopy","volume":"106","author":"Agnoletti","year":"2011","journal-title":"Br J Anaesth"},{"issue":"Suppl 1","key":"10.1016\/j.ccm.2025.02.002_bib67","first-page":"A149","article-title":"P127 Regional erector spinae block for medical thoracoscopy","volume":"77","author":"McPherson","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2025.02.002_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107225","article-title":"Anesthetic considerations for medical pleuroscopy","volume":"213","author":"Sikachi","year":"2023","journal-title":"Respir Med"},{"issue":"Suppl 2","key":"10.1016\/j.ccm.2025.02.002_bib69","doi-asserted-by":"crossref","first-page":"ii54","DOI":"10.1136\/thx.2010.137018","article-title":"Local anaesthetic thoracoscopy: British thoracic society pleural disease guideline 2010","volume":"65","author":"Rahman","year":"2010","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib70","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jama.2019.19997","article-title":"Effect of thoracoscopic talc poudrage vs talc slurry via chest tube on pleurodesis failure rate among patients with malignant pleural effusions: a randomized clinical trial","volume":"323","author":"Bhatnagar","year":"2020","journal-title":"JAMA"},{"issue":"26","key":"10.1016\/j.ccm.2025.02.002_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta24260","article-title":"Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: the TAPPS RCT","volume":"24","author":"Bhatnagar","year":"2020","journal-title":"Health Technol Assess"},{"issue":"Suppl 3","key":"10.1016\/j.ccm.2025.02.002_bib72","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/thorax-2022-219784","article-title":"British Thoracic Society Guideline for pleural disease - appendix D5: pleural malignancy talc poudrage versus talc slurry","volume":"78","author":"Roberts","year":"2023","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.ccm.2025.02.002_bib73","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1378\/chest.10-1868","article-title":"Rapid pleurodesis for malignant pleural effusions: a pilot study","volume":"139","author":"Reddy","year":"2011","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ccm.2025.02.002_bib74","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/LBR.0000000000000186","article-title":"Pleuroscopic pleurodesis combined with tunneled pleural catheter for management of malignant pleural effusion: a prospective observational study","volume":"22","author":"Boujaoude","year":"2015","journal-title":"J Bronchology Interv Pulmonol"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib75","article-title":"The randomised thoracoscopic talc poudrage+indwelling pleural catheters versus thoracoscopic talc poudrage only in malignant pleural effusion trial (TACTIC): study protocol for a randomised controlled trial","volume":"10","author":"Dipper","year":"2023","journal-title":"BMJ Open Respir Res"},{"issue":"19","key":"10.1016\/j.ccm.2025.02.002_bib76","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2017.17426","article-title":"Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE randomized clinical trial","volume":"318","author":"Thomas","year":"2017","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ccm.2025.02.002_bib77","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<1992::AID-CNCR16>3.0.CO;2-M","article-title":"A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions","volume":"86","author":"Putnam","year":"1999","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.ccm.2025.02.002_bib78","doi-asserted-by":"crossref","first-page":"975","DOI":"10.6004\/jnccn.2012.0102","article-title":"Optimal management of malignant pleural effusions (results of CALGB 30102)","volume":"10","author":"Demmy","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"10.1016\/j.ccm.2025.02.002_bib79","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1378\/chest.11-2657","article-title":"Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion","volume":"142","author":"Fysh","year":"2012","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.ccm.2025.02.002_bib80","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S2213-2600(18)30288-1","article-title":"Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial","volume":"6","author":"Muruganandan","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"8","key":"10.1016\/j.ccm.2025.02.002_bib81","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1164\/rccm.201607-1404OC","article-title":"Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions. The ASAP trial","volume":"195","author":"Wahidi","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2025.02.002_bib82","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1378\/chest.129.2.362","article-title":"Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion","volume":"129","author":"Tremblay","year":"2006","journal-title":"Chest"},{"issue":"14","key":"10.1016\/j.ccm.2025.02.002_bib83","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMoa1716883","article-title":"Outpatient talc administration by indwelling pleural catheter for malignant effusion","volume":"378","author":"Bhatnagar","year":"2018","journal-title":"N Engl J Med"},{"issue":"suppl 63","key":"10.1016\/j.ccm.2025.02.002_bib84","article-title":"EPIToME (early pleurodesis via IPC with talc for malignant effusion): evaluation of a new management algorithm","volume":"54","author":"Fitzgerald","year":"2019","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.ccm.2025.02.002_bib85","doi-asserted-by":"crossref","first-page":"2201215","DOI":"10.1183\/13993003.01215-2022","article-title":"The impact of outpatient versus inpatient management on health-related quality of life outcomes for patients with malignant pleural effusion: the OPTIMUM randomised clinical trial","volume":"63","author":"Sivakumar","year":"2024","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.ccm.2025.02.002_bib86","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1513\/AnnalsATS.202111-1301OC","article-title":"Silver nitrate-coated versus standard indwelling pleural catheter for malignant effusions: the SWIFT randomized trial","volume":"19","author":"Shrager","year":"2022","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib87","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejcts.2007.10.002","article-title":"Identification of clinical factors predicting Pleurx catheter removal in patients treated for malignant pleural effusion","volume":"33","author":"Warren","year":"2008","journal-title":"Eur J Cardio Thorac Surg"},{"key":"10.1016\/j.ccm.2025.02.002_bib88","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12890-015-0025-z","article-title":"Important prognostic factors for survival in patients with malignant pleural effusion","volume":"15","author":"Zamboni","year":"2015","journal-title":"BMC Pulm Med"},{"issue":"Suppl 4","key":"10.1016\/j.ccm.2025.02.002_bib89","first-page":"A101","article-title":"S139 experience of using a novel digital drainage system via an indwelling pleural catheter (IPC): a case series","volume":"78","author":"Yousuf","year":"2023","journal-title":"Thorax"},{"issue":"Suppl 4","key":"10.1016\/j.ccm.2025.02.002_bib90","first-page":"A100","article-title":"S138 Malignant pleural effusions: evaluating the psychosocial impact of indwelling pleural catheters on patients (MY-IPC) \u2013 an interim analysis","volume":"78","author":"Zhang","year":"2023","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib92","article-title":"Complications of indwelling pleural catheter use and their management","volume":"3","author":"Lui","year":"2016","journal-title":"BMJ Open Respir Res"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib93","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11606-010-1472-0","article-title":"Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review","volume":"26","author":"Van Meter","year":"2011","journal-title":"J Gen Intern Med"},{"issue":"5","key":"10.1016\/j.ccm.2025.02.002_bib94","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1378\/chest.12-3103","article-title":"Clinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter study","volume":"144","author":"Fysh","year":"2013","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ccm.2025.02.002_bib95","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1378\/chest.11-0724","article-title":"Fractured indwelling pleural catheters","volume":"141","author":"Fysh","year":"2012","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ccm.2025.02.002_bib96","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1378\/chest.13-3057","article-title":"Catheter tract metastasis associated with indwelling pleural catheters","volume":"146","author":"Thomas","year":"2014","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib97","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1186\/s13063-022-06405-7","article-title":"Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (\u00b1talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion","volume":"23","author":"Fitzgerald","year":"2022","journal-title":"Trials"},{"issue":"8","key":"10.1016\/j.ccm.2025.02.002_bib98","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ccm.2025.02.002_bib99","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S2213-2600(24)00119-X","article-title":"Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial","volume":"12","author":"Lim","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"9948","key":"10.1016\/j.ccm.2025.02.002_bib100","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0140-6736(14)60418-9","article-title":"Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial","volume":"384","author":"Rintoul","year":"2014","journal-title":"Lancet"},{"issue":"Suppl 3","key":"10.1016\/j.ccm.2025.02.002_bib101","first-page":"A19","article-title":"S26 Identification and prognostic importance of non-expansile lung following drainage of suspected malignant pleural effusion","volume":"72","author":"Martin","year":"2017","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.ccm.2025.02.002_bib102","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/resp.13681","article-title":"Inter-observer variation in image interpretation and the prognostic importance of non-expansile lung in malignant pleural effusion","volume":"25","author":"Martin","year":"2020","journal-title":"Respirology"},{"issue":"2","key":"10.1016\/j.ccm.2025.02.002_bib103","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1378\/chest.08-2448","article-title":"Is full postpleurodesis lung expansion a determinant of a successful outcome after talc pleurodesis?","volume":"136","author":"Terra","year":"2009","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ccm.2025.02.002_bib104","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1378\/chest.13-2876","article-title":"Novel use of pleural ultrasound can identify malignant entrapped lung prior to effusion drainage","volume":"146","author":"Salamonsen","year":"2014","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.ccm.2025.02.002_bib105","doi-asserted-by":"crossref","first-page":"768","DOI":"10.7326\/0003-4819-126-10-199705150-00003","article-title":"Elastance of the pleural space: a predictor for the outcome of pleurodesis in patients with malignant pleural effusion","volume":"126","author":"Lan","year":"1997","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.ccm.2025.02.002_bib106","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.chest.2019.07.010","article-title":"Pre-EDIT: a randomized feasibility trial of elastance-directed intrapleural catheter or talc pleurodesis in malignant pleural effusion","volume":"156","author":"Martin","year":"2019","journal-title":"Chest"},{"issue":"4 Pt 1","key":"10.1016\/j.ccm.2025.02.002_bib107","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1164\/ajrccm.162.4.9907047","article-title":"Measurement of pleural pressure during therapeutic thoracentesis","volume":"162","author":"Villena","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2025.02.002_bib108","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/diagnostics14020204","article-title":"Ultrasound in the diagnosis of non-expandable lung: a prospective observational study of M-mode, B-mode, and 2D-shear wave elastography","volume":"14","author":"Petersen","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"Suppl 3","key":"10.1016\/j.ccm.2025.02.002_bib109","doi-asserted-by":"crossref","first-page":"A43","DOI":"10.1136\/thoraxjnl-2013-204457.87","article-title":"S80 Post-thoracoscopy lung re-expansion: pilot data using digital suction device","volume":"68","author":"Hallifax","year":"2013","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib110","volume":"6","author":"Matthews","year":"2019","journal-title":"BMJ Open Respir Res"},{"issue":"11","key":"10.1016\/j.ccm.2025.02.002_bib111","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/JTO.0b013e318189f53d","article-title":"Diagnostic and prognostic implications of pleural adhesions in malignant effusions","volume":"3","author":"Bielsa","year":"2008","journal-title":"J Thorac Oncol"},{"issue":"3\u20134","key":"10.1016\/j.ccm.2025.02.002_bib112","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/0218492311410874","article-title":"Streptokinase for malignant pleural effusions: a randomized controlled study","volume":"19","author":"Okur","year":"2011","journal-title":"Asian Cardiovasc Thorac Ann"},{"issue":"6","key":"10.1016\/j.ccm.2025.02.002_bib113","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s12032-015-0612-0","article-title":"The palliative treatment with intrapleural streptokinase in patients with multiloculated malignant pleural effusion: a double-blind, placebo-controlled, randomized study","volume":"32","author":"Saydam","year":"2015","journal-title":"Med Oncol"},{"issue":"5","key":"10.1016\/j.ccm.2025.02.002_bib114","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1556-0864(15)31612-9","article-title":"Intrapleural urokinase for the treatment of loculated malignant pleural effusions and trapped lungs in medically inoperable cancer patients","volume":"1","author":"Hsu","year":"2006","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.1016\/j.ccm.2025.02.002_bib115","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1378\/chest.14-2401","article-title":"Intrapleural fibrinolysis for the treatment of indwelling pleural catheter-related symptomatic loculations: a multicenter observational study","volume":"148","author":"Thomas","year":"2015","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.ccm.2025.02.002_bib116","first-page":"1009","article-title":"Switching off malignant pleural effusion formation-fantasy or future?","volume":"7","author":"Spella","year":"2015","journal-title":"J Thorac Dis"},{"issue":"3","key":"10.1016\/j.ccm.2025.02.002_bib117","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11912-013-0315-7","article-title":"The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusion","volume":"15","author":"Bradshaw","year":"2013","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"10.1016\/j.ccm.2025.02.002_bib118","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3892\/ijo.2021.5174","article-title":"Novel therapies for malignant pleural effusion: anti-angiogenic therapy and immunotherapy (Review)","volume":"58","author":"He","year":"2021","journal-title":"Int J Oncol"},{"issue":"7","key":"10.1016\/j.ccm.2025.02.002_bib119","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/1759-7714.13472","article-title":"Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: a phase II study North East Japan Study group trial NEJ013B","volume":"11","author":"Noro","year":"2020","journal-title":"Thorac Cancer"},{"issue":"1","key":"10.1016\/j.ccm.2025.02.002_bib120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12890-024-02886-1","article-title":"Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion","volume":"24","author":"Zeng","year":"2024","journal-title":"BMC Pulm Med"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523125000048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523125000048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:34:17Z","timestamp":1751387657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523125000048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":118,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0272523125000048"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2025.02.002","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Malignant Pleural Effusions","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2025.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}